David Shaw’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
– Sell
-5,000
Closed -$580K – 3780
2018
Q2
$580K Hold
5,000
– – ﹤0.01% 3031
2018
Q1
$405K Buy
+5,000
New +$385K ﹤0.01% 2982

Other funds holding ENTA

David Shaw's ENTA Position: Q3 2026 in Review

David Shaw increased its Enanta Pharmaceuticals (ENTA) stake by 68% in Q3 2026, buying an estimated $311K and bringing the position to 57,923 shares worth $763K. The position accounts for ﹤0.01% of the portfolio, ranked #4001.

David Shaw first reported a position in ENTA in Q3 2014 and has held it in 39 quarters since. The position peaked at $10M in Q1 2024. 129 funds tracked by Wall St. Rank hold ENTA as of Q3 2026.

  • David Shaw held 57,923 shares of Enanta Pharmaceuticals worth $763K as of Q3 2026.
  • David Shaw bought 23,384 Enanta Pharmaceuticals shares in Q3 2026, an estimated $311K.
  • Enanta Pharmaceuticals made up ﹤0.01% of David Shaw's portfolio in Q3 2026, its #4001 holding.
  • David Shaw first reported a position in Enanta Pharmaceuticals in Q3 2014 and has held it in 39 quarters since.
  • David Shaw's Enanta Pharmaceuticals position peaked at $10M in Q1 2024.
  • 129 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q3 2026.

Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.